These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22087063)

  • 1. Future prospects in the treatment of erectile dysfunction: focus on avanafil.
    Alwaal A; Al-Mannie R; Carrier S
    Drug Des Devel Ther; 2011; 5():435-43. PubMed ID: 22087063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.
    Limin M; Johnsen N; Hellstrom WJ
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1427-37. PubMed ID: 20939743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avanafil for the treatment of erectile dysfunction.
    Zurawin JL; Stewart CA; Anaissie JE; Yafi FA; Hellstrom WJ
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1163-70. PubMed ID: 27416913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avanafil for the treatment of erectile dysfunction.
    Segal R; Burnett AL
    Drugs Today (Barc); 2012 Jan; 48(1):7-15. PubMed ID: 22384456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avanafil for erectile dysfunction.
    Kyle JA; Brown DA; Hill JK
    Ann Pharmacother; 2013 Oct; 47(10):1312-20. PubMed ID: 24259695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avanafil - a further step to tailoring patient needs and expectations.
    Boeri L; Capogrosso P; Ventimiglia E; Serino A; La Croce G; Russo A; Damiano R; Montorsi F; Salonia A
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1171-81. PubMed ID: 27232892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.
    Wang R; Burnett AL; Heller WH; Omori K; Kotera J; Kikkawa K; Yee S; Day WW; DiDonato K; Peterson CA
    J Sex Med; 2012 Aug; 9(8):2122-9. PubMed ID: 22759639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avanafil (Stendra)--another PDE5 inhibitor for erectile dysfunction.
    Med Lett Drugs Ther; 2014 May; 56(1442):37-8. PubMed ID: 24818838
    [No Abstract]   [Full Text] [Related]  

  • 10. Avanafil for treatment of erectile dysfunction: review of its potential.
    Burke RM; Evans JD
    Vasc Health Risk Manag; 2012; 8():517-23. PubMed ID: 22973106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice.
    Mirone V; Fusco F; Parazzini F; Zucchi A
    Arch Ital Urol Androl; 2016 Jul; 88(2):128-32. PubMed ID: 27377089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avanafil: A comprehensive drug profile.
    Al-Majed AA; AlKhairallah A; Attwa MW; Alkahtani HM; El-Azab AS; Abdel-Aziz AA; Alkhider A; Hassan SB; Bakheit AH
    Profiles Drug Subst Excip Relat Methodol; 2024; 49():115-151. PubMed ID: 38423706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Moon KH; Chung WS; Min KS; Suh JK; Hyun JS; Park K; Park JK
    BJU Int; 2012 Dec; 110(11):1801-6. PubMed ID: 22448738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta-analysis.
    Corona G; Rastrelli G; Burri A; Jannini EA; Maggi M
    Expert Opin Drug Saf; 2016; 15(2):237-47. PubMed ID: 26646748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avanafil for male erectile dysfunction: a systematic review and meta-analysis.
    Cui YS; Li N; Zong HT; Yan HL; Zhang Y
    Asian J Androl; 2014; 16(3):472-7. PubMed ID: 24589460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avanafil for the treatment of erectile dysfunction. An updated review.
    Egui-Rojo MA; Moncada-Iribarren I; Carballido-Rodríguez J; Martínez-Salamanca JI
    Arch Esp Urol; 2014 Dec; 67(10):839-47. PubMed ID: 25582903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.
    Goldstein I; McCullough AR; Jones LA; Hellstrom WJ; Bowden CH; Didonato K; Trask B; Day WW
    J Sex Med; 2012 Apr; 9(4):1122-33. PubMed ID: 22248153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approves new ED remedy.
    Traynor K
    Am J Health Syst Pharm; 2012 Jun; 69(11):906. PubMed ID: 22610014
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness and safety of avanafil for erectile dysfunction: a systematic review and meta-analysis.
    Wang H; Yuan J; Hu X; Tao K; Liu J; Hu D
    Curr Med Res Opin; 2014 Aug; 30(8):1565-71. PubMed ID: 24701971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.